Douglass Winthrop Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-364
| Closed | -$259K | – | 292 |
|
|
2024
Q4 | $259K | Buy |
364
+150
| +70% | +$107K | 0.01% | 264 |
|
|
2024
Q3 | $225K | Hold |
214
| – | – | ﹤0.01% | 274 |
|
|
2024
Q2 | $225K | Hold |
214
| – | – | ﹤0.01% | 264 |
|
|
2024
Q1 | $206K | Buy |
+214
| New | +$206K | ﹤0.01% | 274 |
|
|
2022
Q3 | – | Sell |
-401
| Closed | -$237K | – | 255 |
|
|
2022
Q2 | $237K | Buy |
+401
| New | +$237K | 0.01% | 230 |
|
|
2017
Q1 | – | Sell |
-775
| Closed | -$284K | – | 248 |
|
|
2016
Q4 | $284K | Buy |
775
+100
| +15% | +$36.6K | 0.02% | 200 |
|
|
2016
Q3 | $271K | Buy |
675
+25
| +4% | +$10K | 0.02% | 210 |
|
|
2016
Q2 | $227K | Hold |
650
| – | – | 0.02% | 222 |
|
|
2016
Q1 | $234K | Buy |
650
+250
| +63% | +$90K | 0.02% | 206 |
|
|
2015
Q4 | $217K | Buy |
+400
| New | +$217K | 0.02% | 217 |
|
|
2015
Q1 | – | Sell |
-6,580
| Closed | -$2.7M | – | 268 |
|
|
2014
Q4 | $2.7M | Buy |
6,580
+30
| +0.5% | +$12.3K | 0.24% | 62 |
|
|
2014
Q3 | $2.36M | Hold |
6,550
| – | – | 0.22% | 62 |
|
|
2014
Q2 | $1.85M | Hold |
6,550
| – | – | 0.17% | 66 |
|
|
2014
Q1 | $1.97M | Hold |
6,550
| – | – | 0.19% | 63 |
|
|
2013
Q4 | $1.8M | Hold |
6,550
| – | – | 0.19% | 65 |
|
|
2013
Q3 | $2.05M | Hold |
6,550
| – | – | 0.24% | 60 |
|
|
2013
Q2 | $1.47M | Buy |
+6,550
| New | +$1.47M | 0.18% | 68 |
|